Expression of cytokeratin confers multiple drug resistance
- PMID: 7515497
- PMCID: PMC43984
- DOI: 10.1073/pnas.91.12.5311
Expression of cytokeratin confers multiple drug resistance
Abstract
The cytokeratin network is an extensive filamentous structure in the cytoplasm whose biological function(s) is unknown. Based upon previous data showing the modification of cytokeratin by mitoxantrone, we investigated the ability of cytokeratin networks to influence the survival response of cells to chemotherapeutic agents. We have compared the survival of mouse L fibroblasts lacking cytokeratins with that of L cells transfected with cytokeratins 8 and 18 in the presence of chemotherapeutic drugs. The expression of cytokeratins 8 and 18 conferred a multiple drug resistance phenotype on cells exposed to mitoxantrone, doxorubicin, methotrexate, melphalan, Colcemid, and vincristine. The degree of drug resistance was 5-454 times that of parental cells, depending upon the agent used. Drug resistance could not be attributed to altered growth characteristics, altered drug accumulation, or an altered drug efflux in the transfected cells. Cytokeratin does not confer resistance to ionizing radiation, which damages DNA independently of intracellular transport mechanisms. These data suggest a role for cytokeratin networks in conferring a drug resistance phenotype.
Similar articles
-
Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents.Clin Cancer Res. 1996 Jan;2(1):97-105. Clin Cancer Res. 1996. PMID: 9816096
-
Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.Life Sci. 2008 Sep 26;83(13-14):496-501. doi: 10.1016/j.lfs.2008.07.017. Epub 2008 Aug 3. Life Sci. 2008. PMID: 18725232
-
Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants.Int J Cancer. 2003 Dec 10;107(5):757-63. doi: 10.1002/ijc.11484. Int J Cancer. 2003. PMID: 14566825
-
Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.Cancer Res. 1995 Nov 15;55(22):5342-7. Cancer Res. 1995. PMID: 7585598
-
Multiple drug resistance and intermediate filaments.Cancer Metastasis Rev. 1996 Dec;15(4):499-506. doi: 10.1007/BF00054015. Cancer Metastasis Rev. 1996. PMID: 9034606 Review.
Cited by
-
Keratins in health and cancer: more than mere epithelial cell markers.Oncogene. 2011 Jan 13;30(2):127-38. doi: 10.1038/onc.2010.456. Epub 2010 Oct 4. Oncogene. 2011. PMID: 20890307 Free PMC article. Review.
-
Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivo.Biophys J. 2023 Nov 7;122(21):4194-4206. doi: 10.1016/j.bpj.2023.09.016. Epub 2023 Sep 26. Biophys J. 2023. PMID: 37766428 Free PMC article.
-
Intermediate Filaments in Breast Cancer Progression, and Potential Biomarker for Cancer Therapy: A Narrative Review.Breast Cancer (Dove Med Press). 2024 Oct 14;16:689-704. doi: 10.2147/BCTT.S489953. eCollection 2024. Breast Cancer (Dove Med Press). 2024. PMID: 39430570 Free PMC article. Review.
-
Recapitulating tumour microenvironment in chitosan-gelatin three-dimensional scaffolds: an improved in vitro tumour model.J R Soc Interface. 2012 Dec 7;9(77):3288-302. doi: 10.1098/rsif.2012.0564. Epub 2012 Sep 12. J R Soc Interface. 2012. PMID: 22977099 Free PMC article.
-
Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers.Am J Transl Res. 2016 Feb 15;8(2):940-54. eCollection 2016. Am J Transl Res. 2016. PMID: 27158381 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources